WuXi AppTec (OTCMKTS:WUXAY) Shares Down 4.3% – Here’s What Happened

Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) fell 4.3% on Monday . The company traded as low as $15.99 and last traded at $15.99. 201 shares traded hands during trading, a decline of 89% from the average session volume of 1,812 shares. The stock had previously closed at $16.7132.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. The Goldman Sachs Group upgraded shares of WuXi AppTec to a “buy” rating in a research report on Thursday, February 5th. Zacks Research raised WuXi AppTec to a “hold” rating in a research note on Monday, April 13th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

WuXi AppTec Price Performance

The business’s 50-day moving average is $15.63 and its two-hundred day moving average is $14.57.

WuXi AppTec (OTCMKTS:WUXAY) last announced its quarterly earnings results on Monday, April 27th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.05. The firm had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.59 billion.

About WuXi AppTec

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.